Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

4.700 USD +0.130 (+2.84%)
Streaming Delayed Price Updated: 5:28 AM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,157
Open 4.570
Bid (Size) 4.600 (1)
Ask (Size) 5.050 (13)
Prev. Close 4.570
Today's Range 4.570 - 4.950
52wk Range 1.100 - 7.030
Shares Outstanding 13,896,926
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Best Penny Stocks To Buy Today? 4 Biotech Stocks To Watch Now
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Genprex to Present its Cutting-Edge Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
Genprex's CEO will present at the MoneyShow Virtual Conference on January 28. 
From Business Wire News Releases

Performance

YTD
+13.80%
+13.80%
1 Month
-1.05%
-1.05%
3 Month
+47.34%
+47.34%
6 Month
+28.07%
+28.07%
1 Year
+285.25%
+285.25%

More News

Read More
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present Trailblazing Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
From InvestorBrandNetwork
Genprex to Present at NobleCon17 on January 19
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Slated to Present at NobleCon17
From InvestorBrandNetwork
Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Passes Final Release Tests for Manufacturing Run of Proprietary Immunogene Therapy Treatment
From InvestorBrandNetwork
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures $12M in Registered Direct Offering
From InvestorBrandNetwork
Interesting GNPX Call Options For February 19th
Tags Stocks
From Market News Video
Genprex, Inc. Announces Closing Of $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Without Warrants
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters into Estimated $12-Million Securities Purchase Agreement
From InvestorBrandNetwork
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.